No abstract available
MeSH terms
-
Actuarial Analysis
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Marrow Purging / adverse effects
-
Bone Marrow Transplantation* / adverse effects
-
Bone Marrow Transplantation* / mortality
-
Child
-
Combined Modality Therapy
-
Female
-
Graft vs Host Disease / etiology
-
Graft vs Host Disease / prevention & control
-
Graft vs Host Disease / therapy
-
Humans
-
Immunologic Factors / therapeutic use
-
Incidence
-
Leukemia, Myeloid, Acute / mortality
-
Leukemia, Myeloid, Acute / surgery*
-
Leukemia, Myeloid, Acute / therapy
-
Male
-
Neoplasms, Multiple Primary / etiology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Prognosis
-
Remission Induction
-
Survival Analysis
-
Survival Rate
-
Transplantation, Autologous
-
Transplantation, Homologous
-
Treatment Outcome